CoChat

Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats

Open access
Allen, Patricia J., D'Anci, Kristen E., Kanarek, Robin B., Renshaw, Perry F. · 2012 · Pharmacology Biochemistry and Behavior
Cited by 60

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The potential role of metabolic impairments in the pathophysiology of depression is motivating researchers to evaluate the treatment efficacy of creatine, a naturally occurring energetic and neuroprotective compound found in brain and muscle tissues. Growing evidence is demonstrating the benefit of oral creatine supplements for reducing depressive symptoms in humans and animals. A novel question is whether dietary creatine, when combined with antidepressant drug therapy, would be more effective than either compound alone. To answer this question, four studies were conducted to investigate the behavioral effects of combined creatine and low-dose fluoxetine treatment using the forced swim test in male and female rats. Sprague-Dawley rats were fed powdered rodent chow supplemented with 0%, 2% or 4% w/w creatine monohydrate for 5 weeks. Rats were injected with fluoxetine (5.0 or 10.0 mg/kg) or saline according to a sub-acute dosing schedule. Female rats maintained on a 4% creatine diet displayed antidepressant-like effects compared to non-supplemented females prior to fluoxetine treatment. In contrast, creatine did not alter behavior reliably in males. Following drug treatment and a second forced swim trial, the antidepressant-like profile of creatine remained significant only in females co-administered 5.0 mg/kg fluoxetine. Moreover, in females only, supplementation with 4% creatine produced a more robust antidepressant-like behavioral profile compared to either dose of fluoxetine alone. Estrous cycle data indicated that ovarian hormones influenced the antidepressant-like effects of creatine. Addressing the issue of sex differences in response to treatment may affect our understanding of creatine, its relationship with depressive behavior, and may lead to sex-specific therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pbb.2012.03.005

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 69

  1. Agostinho, 2009, Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain, Brain Res Bull, 80, 337, 10.1016/j.brainresbull.2009.09.002 · DOI
  2. Agren, 1988, Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note, J Neural Transm, 74, 55, 10.1007/BF01243575 · DOI · Paper page
  3. Allen, 2010, Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner, Neuropsychopharmacology, 35, 534, 10.1038/npp.2009.160 · DOI · Paper page
  4. Almeida, 2006, Exocytotic release of creatine in rat brain, Synapse, 60, 118, 10.1002/syn.20280 · DOI
  5. Amital, 2006, Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder, J Clin Psychiatry, 67, 836, 10.4088/JCP.v67n0521c · DOI · Paper page
  6. Amital, 2006, Observed effects of creatine monohydrate in a patient with depression and fibromyalgia, Am J Psychiatry, 163, 1840, 10.1176/appi.ajp.163.10.1840-b · DOI
  7. Andres, 2008, Functions and effects of creatine in the central nervous system, Brain Res Bull, 76, 329, 10.1016/j.brainresbull.2008.02.035 · DOI · Paper page
  8. Andres, 2005, Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue, Neuroscience, 133, 701, 10.1016/j.neuroscience.2005.03.004 · DOI
  9. Arnold, 2009, Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target, J Neurochem, 110, 1, 10.1111/j.1471-4159.2009.06133.x · DOI · Paper page
  10. Assis, 2009, Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats, Rev Bras Psiquiatr, 31, 247, 10.1590/S1516-44462009000300010 · DOI · Paper page
  11. Behl, 2002, Estrogen can protect neurons: modes of action, J Steroid Biochem Mol Biol, 83, 195, 10.1016/S0960-0760(02)00271-6 · DOI
  12. Blokland, 2012, The use of a test battery assessing affective behavior in rats: order effects, Behav Brain Res, 228, 16, 10.1016/j.bbr.2011.11.042 · DOI
  13. Búrigo, 2006, Decreased creatine kinase activity caused by electroconvulsive shock, Neurochem Res, 31, 877, 10.1007/s11064-006-9091-1 · DOI
  14. Cryan, 2005, Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment, Psychopharmacology (Berl), 182, 335, 10.1007/s00213-005-0093-5 · DOI · Paper page
  15. Cryan, 2005, Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test, Neurosci Biobehav Rev, 29, 547, 10.1016/j.neubiorev.2005.03.008 · DOI · Paper page
  16. Czéh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc Natl Acad Sci, 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
  17. Dager, 2004, Brain metabolic alterations in medication-free patients with bipolar disorder, Arch Gen Psychiatry, 61, 450, 10.1001/archpsyc.61.5.450 · DOI · Paper page
  18. Dalla, 2009, Sex differences in learning processes of classical and operant conditioning, Physiol Behav, 97, 229, 10.1016/j.physbeh.2009.02.035 · DOI · Paper page
  19. Detke, 1995, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology (Berl), 121, 66, 10.1007/BF02245592 · DOI · Paper page
  20. Detke, 1997, Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression, Exp Clin Psychopharmacol, 5, 107, 10.1037/1064-1297.5.2.107 · doi:10.1037/1064-1297.5.2.107 · Paper page
  21. Erakovic, 2001, Altered activities of rat brain metabolic enzymes in electroconvulsive shock-induced seizures, Epilepsia, 42, 181, 10.1046/j.1528-1157.2001.30499.x · DOI · Paper page
  22. Fuchs, 2002, Synaptic plasticity and tianeptine: structural regulation, Eur Psychiatry, 17, 311, 10.1016/S0924-9338(02)00652-1 · DOI · Paper page
  23. Gabbay, 2007, Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study, Am J Psychiatry, 164, 1881, 10.1176/appi.ajp.2007.06122032 · DOI
  24. Gledhill, 1988, Race–gender differences in serum creatine kinase activity: a study among South Africans, J Neurol Neurosurg Psychiatry, 51, 301, 10.1136/jnnp.51.2.301 · DOI · Paper page
  25. Hamakawa, 1999, Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder, Psychol Med, 29, 639, 10.1017/S0033291799008442 · DOI · Paper page
  26. Heisler, 1997, Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats, Pharmacol Biochem Behav, 58, 767, 10.1016/S0091-3057(97)00036-1 · doi:10.1016/s0091-3057(97)00036-1
  27. Heisler, 1999, Reduction of fat and protein intakes but not carbohydrate intake following acute and chronic fluoxetine in female rats, Pharmacol Biochem Behav, 63, 377, 10.1016/S0091-3057(99)00021-0 · DOI
  28. Higuchi, 2009, Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients, Neuropsychiatr Dis Treat, 5, 151
  29. Hroudová, 2011, Connectivity between mitochondrial functions and psychiatric disorders, Psychiatry Clin Neurosci, 65, 130, 10.1111/j.1440-1819.2010.02178.x · DOI · Paper page
  30. Hui, 2007, Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs, J Pharmacol Toxicol Methods, 56, 256, 10.1016/j.vascn.2007.05.006 · DOI
  31. Iosifescu, 2008, Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder, Biol Psychiatry, 63, 1127, 10.1016/j.biopsych.2007.11.020 · DOI · Paper page
  32. Ji, 2008, The Visceromotor response to colorectal distention fluctuates with the estrous cycle in rats, Neuroscience, 154, 1562, 10.1016/j.neuroscience.2008.04.070 · DOI
  33. Kim, 2010, Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo 1H-MRS study at 9.4T, Brain Res, 1348, 105, 10.1016/j.brainres.2010.05.097 · DOI
  34. Koga, 2005, Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks, Neuroscience, 132, 65, 10.1016/j.neuroscience.2005.01.004 · DOI
  35. Kondo, 2011, Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study, J Affect Disord, 135, 354, 10.1016/j.jad.2011.07.010 · DOI · Paper page
  36. Kondo, 2011, Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder, Depress Res Treat, 1, 10.1155/2011/650450 · DOI · Paper page
  37. Kornstein, 2000, Gender differences in chronic major and double depression, J Affect Disord, 60, 1, 10.1016/S0165-0327(99)00158-5 · DOI · Paper page
  38. Leuner, 2004, Males and females respond differently to controllability and antidepressant treatment, Biol Psychiatry, 56, 964, 10.1016/j.biopsych.2004.09.018 · DOI
  39. Lyoo, 2002, Magnetic resonance spectroscopy: current and future applications in psychiatric research, Biol Psychiatry, 51, 195, 10.1016/S0006-3223(01)01313-0 · DOI
  40. Maletic, 2007, Neurobiology of depression: an integrated view of key findings, Int J Clin Pract, 61, 2030, 10.1111/j.1742-1241.2007.01602.x · DOI · Paper page
  41. Malnick, 1983, Estrogen-induced creatine kinase in the reproductive system of the immature female rat, Endocrinology, 113, 1907, 10.1210/endo-113-5-1907 · DOI
  42. Michael, 2003, Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression, Psychol Med, 33, 1277, 10.1017/S0033291703007931 · DOI · Paper page
  43. Michael-Titus, 2008, SONU20176289, a compound combining partial dopamine D2 receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression, Eur J Pharmacol, 598, 43, 10.1016/j.ejphar.2008.09.006 · DOI
  44. Mirza, 2006, Increased medial thalamic creatine–phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive–compulsive disorder versus major depression and healthy controls, J Child Neurol, 21, 106, 10.1177/08830738060210020201 · DOI
  45. Moore, 1997, Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study, Am J Psychiatry, 154, 116, 10.1176/ajp.154.1.116 · DOI · Paper page
  46. Moretti, 2003, Affective disorders, antidepressant drugs and brain metabolism, Mol Psychiatry, 8, 773, 10.1038/sj.mp.4001353 · DOI
  47. Nery, 2009, Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel 1H spectroscopy study, Psychiatry Res, 174, 177, 10.1016/j.pscychresns.2009.05.003 · DOI
  48. Niklasson, 1984, Brain energy metabolism and blood–brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood, Biol Psychiatry, 19, 1183
  49. Oliveira, 2008, The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement, Behav Brain Res, 187, 200, 10.1016/j.bbr.2007.09.004 · DOI
  50. Page, 1999, Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test, Psychopharmacology (Berl), 147, 162, 10.1007/s002130051156 · DOI · Paper page
  51. Perasso, 2003, Kinetics of creatine in blood and brain after intraperitoneal injection in the rat, Brain Res, 974, 37, 10.1016/S0006-8993(03)02547-2 · DOI
  52. Persky, 2003, Single- and multiple-dose pharmacokinetics of oral creatine, J Clin Pharmacol, 43, 29, 10.1177/0091270002239703 · DOI · Paper page
  53. Prut, 2003, The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review, Eur J Pharmacol, 463, 3, 10.1016/S0014-2999(03)01272-X · DOI · Paper page
  54. Ramirez, 2002, Sexual dimorphism in rat cerebrum and cerebellum: different patterns of catalytically active creatine kinase isoenzymes during postnatal development and aging, Int J Dev Neurosci, 20, 627, 10.1016/S0736-5748(02)00102-8 · DOI
  55. Renshaw, 2001, Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression, Am J Psychiatry, 158, 2048, 10.1176/appi.ajp.158.12.2048 · DOI · Paper page
  56. Rezin, 2008, Mitochondrial dysfunction and psychiatric disorders, Neurochem Res, 34, 1021, 10.1007/s11064-008-9865-8 · DOI · Paper page
  57. Santos, 2009, Brain creatine kinase activity is increased by chronic administration of paroxetine, Brain Res Bull, 80, 327, 10.1016/j.brainresbull.2009.09.007 · DOI
  58. Segal, 2007, Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients, Eur Neuropsychopharmacol, 17, 194, 10.1016/j.euroneuro.2006.08.010 · DOI
  59. Sestili, 2011, Creatine as an antioxidant, Amino Acids, 40, 1385, 10.1007/s00726-011-0875-5 · DOI · Paper page
  60. Sömjen, 1991, Regulation of proliferation of rat cartilage and bone by sex steroid hormones, J Steroid Biochem Mol Biol, 40, 717, 10.1016/0960-0760(91)90296-H · DOI
  61. Sora, 1986, Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders, Biol Psychiatry, 21, 621, 10.1016/0006-3223(86)90123-X · DOI
  62. Spence, 2012, Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration, Front Neuroendocrinol, 33, 105, 10.1016/j.yfrne.2011.12.001 · DOI · Paper page
  63. Venkatraman, 2009, Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression, Psychiatry Res, 172, 49, 10.1016/j.pscychresns.2008.07.001 · DOI · Paper page
  64. Vermeiden, 2009, Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients, J Psychopharmacol (Oxf), 24, 497, 10.1177/0269881109105137 · DOI
  65. Volz, 1998, 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients, Eur Arch Psychiatry Clin Neurosci, 248, 289, 10.1007/s004060050052 · DOI · Paper page
  66. Walf, 2009, Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model, Gend Med, 6, 300, 10.1016/j.genm.2009.04.004 · DOI
  67. Wallimann, 1992, Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis, Biochem J, 281, 21, 10.1042/bj2810021 · DOI · Paper page
  68. Wong, 1983, Heterogeneity of serum creatine kinase activity among racial and gender groups of the population, Am J Clin Pathol, 79, 582, 10.1093/ajcp/79.5.582 · DOI · Paper page
  69. Young, 2009, Sex differences in response to citalopram: a STAR∗D report, J Psychiatr Res, 43, 503, 10.1016/j.jpsychires.2008.07.002 · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F.
Venue
Pharmacology Biochemistry and Behavior
Publisher
Elsevier BV
Published
2012-06
Volume
101
Issue
4
Pages
588-601
ISSN
0091-3057 (ISSN-L)
OpenAlex
W2036852450
Cited by
60
References
15
FWCI
3.51
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. https://app.cochat.ai/papers/10.1016/j.pbb.2012.03.005
The paper
Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2012). Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2012.03.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.